These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 17131689

  • 1. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract] [Full Text] [Related]

  • 2. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct 23; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 4. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
    Mott TF, Leach L, Johnson L.
    J Fam Pract; 2004 Aug 23; 53(8):659-61. PubMed ID: 15298843
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
    Fernández-Jaén A, Fernández-Mayoralas DM, Pardos A, Calleja-Pérez B, Muñoz Jareño N.
    Adv Ther; 2009 Dec 23; 26(12):1097-110. PubMed ID: 20082241
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 23; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 7. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H, Lewis J.
    Atten Defic Hyperact Disord; 2012 Mar 23; 4(1):37-9. PubMed ID: 22311620
    [Abstract] [Full Text] [Related]

  • 8. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 23; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 9. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun 19; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract] [Full Text] [Related]

  • 10. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF, Vergnaud S, Mouren MC.
    Arch Pediatr; 2006 Jan 19; 13(1):100-3. PubMed ID: 16239100
    [Abstract] [Full Text] [Related]

  • 11. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A.
    Pediatrics; 2004 Oct 19; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
    Prince JB.
    Child Adolesc Psychiatr Clin N Am; 2006 Jan 19; 15(1):13-50. PubMed ID: 16321724
    [Abstract] [Full Text] [Related]

  • 13. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A, Richard C, Prinzo R, Binder C.
    Curr Med Res Opin; 2006 Dec 19; 22(12):2557-66. PubMed ID: 17166338
    [Abstract] [Full Text] [Related]

  • 14. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Quinn D, Bode T, Reiz JL, Donnelly GA, Darke AC.
    J Clin Pharmacol; 2007 Jun 19; 47(6):760-6. PubMed ID: 17395894
    [Abstract] [Full Text] [Related]

  • 15. Medication for children with attention disorders.
    Kash IJ.
    Pediatrics; 1997 Jun 19; 99(6):922-3. PubMed ID: 9164792
    [No Abstract] [Full Text] [Related]

  • 16. Optimizing ADHD therapy with sustained-release methylphenidate.
    Lawrence JD, Lawrence DB, Carson DS.
    Am Fam Physician; 1997 Apr 19; 55(5):1705-9, 1711-2. PubMed ID: 9105199
    [Abstract] [Full Text] [Related]

  • 17. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.
    Psychiatr Pol; 2009 Apr 19; 43(2):183-92. PubMed ID: 19697788
    [Abstract] [Full Text] [Related]

  • 18. [Attention deficit hyperactivity disorder in children].
    Bervoets L.
    J Pharm Belg; 2002 Apr 19; 57(2):25-32. PubMed ID: 12053824
    [No Abstract] [Full Text] [Related]

  • 19. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A, Yamashita Y, Koeda T, Hiratani M, Kaneko M, Yamada S, Matsuishi T.
    Ann Neurol; 2002 Sep 19; 52(3):372-4. PubMed ID: 12205654
    [Abstract] [Full Text] [Related]

  • 20. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW, van den Anker JN.
    Ned Tijdschr Geneeskd; 2000 Nov 11; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.